Shares of Jasper Therapeutics are up 5.9% afterhours at $1.80 as the company discloses in a Form 4 filing that Carlyle Group has purchased 3.13M shares of common stock on January 27th in a total transaction size of $4.7M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on JSPR:
- Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023
- Jasper Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Jasper Therapeutics 60M share Spot Secondary priced at $1.50
- Jasper Therapeutics announces pricing of $90M public offering
- Jasper Therapeutics Announces Pricing of $90 Million Public Offering of Common Stock